34 studies found for:
"Acinic cell carcinoma"
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Terminated |
Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
|
||||
2 | Active, not recruiting |
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
|
||||
3 | Unknown † |
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
|
||||
4 | Recruiting |
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
|
||||
5 | Recruiting |
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer
|
||||
6 | Not yet recruiting |
Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
|
||||
7 | Recruiting |
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
|
||||
8 | Not yet recruiting |
Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery
|
||||
9 | Completed |
Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride
|
||||
10 | Active, not recruiting |
Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
|
||||
11 | Recruiting |
Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
|
||||
12 | Not yet recruiting |
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed By Surgery
|
||||
13 | Completed |
Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine
|
||||
14 |
Terminated
Has Results |
Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer
|
||||
15 | Not yet recruiting |
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung
|
||||
16 | Recruiting |
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
|
||||
17 | Active, not recruiting |
Head & Neck Cancer Survivorship: Physical and Functional Status
|
||||
18 | Completed |
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
|
||||
19 |
Completed
Has Results |
Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema
|
||||
20 | Recruiting |
Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung
|
† Indicates status has not been verified in more than two years